Andy Futreal, Ph.D.
The Department of Genomic Medicine aims to advance precision cancer care through an integrated approach across the MD Anderson community and ultimately around the globe. The diverse faculty and staff within the Genomic Medicine consist of primary faculty, adjunct faculty with dual appointment in other departments, and numerous outstanding individuals dedicated to advancing cancer care through technology and innovation.
Our multifaceted program has several components:
- Independent laboratories focused on deciphering the role of cancer genomics and therapeutic responses.
- Discovery efforts to characterize somatic epi/genomic alterations and germline variations in multiple cancer types (through the Cancer Genomics Laboratory and other independent laboratories within Genomic Medicine), and efforts to understand the complex interplay between cancer genomics and anti-tumor immune responses
- Functional characterization and mechanistic studies to identify those differences that are most likely to be relevant to disease, with the identification and validation of therapeutic targets and biomarkers utilizing diverse model systems (in collaboration with the Institute for Applied Cancer Science - IACS, the Center for Co-Clinical Trials - CCCT, and the Oncology Research for Biologics and Immunotherapy Translation – ORBIT)
- Translational efforts with clinical samples and associated clinical and research data in collaboration with MD Anderson clinicians and investigators within and outside of the Moon Shot Program™ and APOLLO (Adaptive Patient-Oriented Longitudinal Learning and Optimization) and Big Data platforms.
Congratulations to our Chair, Andy Futreal, Ph.D., for being awarded the 2018 Emil Frei, III Award for Excellence in Translational Research at Cancer Medicine’s 13th Annual Faculty Recognition & Awards Program on Dec. 7, 2018.
Related Programs & Labs